<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":2519,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
WM. Wrigley Jr. Co. v. Cadbury Adams USA LLC, 683 F.3d 1356, 103 U.S.P.Q.2d 1130 (Fed. Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/58c2f496a749056dc16e85a8d800c33c'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/58c2f496a749056dc16e85a8d800c33c'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1HSV5C003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1HSV5C003">Previous Result: <span>Wineman v. City of Keego Harbor, Case No...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1HSV5I003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1HSV5I003">Next Result: <span>Zayed v. Peregrine Financial Group, Inc....</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='WM. Wrigley Jr. Co. v. Cadbury Adams USA LLC, 683 F.3d 1356, 103 U.S.P.Q.2d 1130 (Fed. Cir. 2012), Court Opinion'>
WM. Wrigley Jr. Co. v. Cadbury Adams USA LLC, 683 F.3d 1356, 103 U.S.P.Q.2d 1130 (Fed. Cir....
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>WM. Wrigley Jr. Co. v. Cadbury Adams USA LLC, 683 F.3d 1356, 103 U.S.P.Q.2d 1130 (Fed. Cir. 2012), Court Opinion</div>
<div class='docId'>X1HSQVU003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>WM. Wrigley Jr. Co. v. Cadbury Adams USA LLC</div>
<div class='displayCitation'>103 U.S.P.Q.2d 1130</div>
<div class='displayCitation'>2012 BL 154971</div>
<div class='displayCitation'>683 F.3d 1356</div>
<div class='displayCitation'>bna a0d3h1q1a3</div>
<div class='displayCitation'>bna a0d3j1c2e7</div>
<div class='displayCitation'>wkffecase:26162687</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1HSQVU003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="WM. Wrigley Jr. Co. v. Cadbury Adams USA LLC, 683 F.3d 1356, 103 U.S.P.Q.2d 1130 (Fed. Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="WM. Wrigley Jr. Co. v. Cadbury Adams USA LLC" />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1HSQVU003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1HSQVU003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1HSQVU003" /><input id="title" name="title" type="hidden" value="WM. Wrigley Jr. Co. v. Cadbury Adams USA LLC, 683 F.3d 1356, 103 U.S.P.Q.2d 1130 (Fed. Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="58c2f496a749056dc16e85a8d800c33c" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1HSQVU003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="true" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%35%38c%32f%34%39%36a%37%34%39%30%35%36dc%31%36e%38%35a%38d%38%30%30c%33%33c%2Fdocument%2FX%31HSQVU%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/bcite/X1HSQVU003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/bcite/X1HSQVU003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/bcite/X1HSQVU003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/related_content/X1HSQVU003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1714597855235";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,ReporterOfDecisions,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">683 F.3d 1356</div>
<div class="cite" data-cite-type="ReporterOfDecisions">103 U.S.P.Q.2d 1130</div>
<div class="cite" data-cite-type="DocketNumber">Nos. 2011-1140, 2011-1150.</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 154971</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">U.S.P.Q.2d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">***</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Federal Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
WM. WRIGLEY JR. CO., Plaintiff-Appellant, v. CADBURY ADAMS USA LLC,
Defendant-Cross Appellant.
</center></p>
<hr align="center" width="65%">
<p><center>
Nos. 2011-1140, 2011-1150.
</center></p>
<p><center>
June 22, 2012.
</center></p>
<div class="headnotesToggle clearfix"><button id="toggle_headnotes_button" class="bootstrap skinButton sourceButton wide right hideSource" data-target="#headnotes_container"><span>Hide Headnotes</span></button></div>
<div class="headnotesContainer" id="headnotes_container">
<div class="headnotesContainerTitle">BNA Headnotes</div>
<div class="headnoteTitle"><a href="http://www.bloomberglaw.com/document/1475619602000128">U.S. Patents Quarterly</a></div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">PATENTS</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_921365" href="#headnote_ref_pq2-dec_921365">[1]</a> <span>Patentability/Validity &mdash; Anticipation &mdash; Identity of elements </span> <a href="http://www.bloomberglaw.com/document/1714597855235/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=115.0704" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="115.0704">&#9658;115.0704</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_1" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_1" class="headnoteContent"></div>
<div class="headnote_text">
Prior art patent anticipates claim of patent
 for chewing gum containing combination of menthol and physiological cooling agent &ldquo;WS-23,&rdquo; even though prior art reference discloses numerous different combinations of cooling and flavoring agents, since one combination disclosed is menthol, which reference identifies as being among &ldquo;most suitable&rdquo; flavoring agents, combined with WS-23, which reference identifies as one of three &ldquo;particularly preferred&rdquo; cooling agents, and  since reference discloses component amounts within ranges specified in claim, and specifically discloses use of both WS-23 and menthol in chewing gum.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_921366" href="#headnote_ref_pq2-dec_921366">[2]</a> <span>Patentability/Validity &mdash; Obviousness &mdash; Combining references </span> <a href="http://www.bloomberglaw.com/document/1714597855235/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=115.0905" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="115.0905">&#9658;115.0905</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_2" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_2" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Patentability/Validity &mdash; Obviousness &mdash; Secondary considerations generally </span> <a href="http://www.bloomberglaw.com/document/1714597855235/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=115.0907" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="115.0907">&#9658;115.0907</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_3" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_3" class="headnoteContent"></div>
<div class="headnote_text">
Evidence that combination of known components results in effect greater than predicted additive effect of components can support finding of nonobviousness; in present case, however, claim for chewing gum containing combination of menthol and physiological cooling agent &ldquo;WS-23&rdquo; was properly held invalid for obviousness over combination of two prior art references, despite patentee's argument that combining WS-23 and menthol resulted in unexpected cooling sensation beyond what would have been predicted by person of ordinary skill in art, since record shows that synergistic effect of combining coolants had already been discovered, since internal study conducted by infringement defendant, comparing parties' products, does not show that broadly claimed combination recited in claim results in unexpected cooling beyond degree already predictable, since evidence does not show that commercial success of plaintiff's product, or defendant's alleged copying of invention, was directly attributable to combining WS-23 with menthol, and since claim recites combination of elements that were known in prior art, and all that was required to obtain claimed combination was to substitute WS-23 for another well-known cooling agent, &ldquo;WS-3.&rdquo;</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_921367" href="#headnote_ref_pq2-dec_921367">[3]</a> <span>Infringement &mdash; Doctrine of equivalents &mdash; In general </span> <a href="http://www.bloomberglaw.com/document/1714597855235/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.0701" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.0701">&#9658;120.0701</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_4" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_4" class="headnoteContent"></div>
<div class="headnote_text">
Claimed chewing gum formulation containing menthol and &ldquo;N-substituted-p-menthane carboxamide&rdquo; is not infringed, under doctrine of equivalents, by accused gum formulation that employs combination of menthol and physiological cooling agent &ldquo;WS-23,&rdquo;
which is not N-substituted-p-menthane carboxamide, since patent's disclosure focuses narrowly on N-substituted-p-menthane carboxamides, not on carboxamides generally, and patent claims only subset of N-substituted-p-menthane carboxamide compounds, and since record shows that inventors were on notice of potential interchangeability of WS-23 and N-substituted-p-menthane carboxamide &ldquo;WS-3,&rdquo; yet they drafted claims of patent to narrowly recite certain N-substituted-p-menthane carboxamides, rather than broader category of carboxamides that would encompass WS-23.</div>
</div>
</div>
<script type="text/javascript">
					jQuery(function($) {
						$('#toggle_headnotes_button').click(document_toggleHeadnoteVisibility);
					});
				</script><div id="para2" printdualcolumn="true"><p>
<span CLASS="page_no" data-cite="103 uspq 2d 1131" data-cite-type="ReporterOfDecisions" data-cite-pageno="1131" data-primary-citation="103 U.S.P.Q.2d 1130">[**1131]</span> Appeal from the United States District Court for the Northern District of
Illinois, Robert M. Dow, Jr. J.
<span CLASS="page_no" data-cite="683 f 3d 1357" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1357" data-primary-citation="683 F.3d 1356">[*1357]</span> 
[EDITORS' NOTE: THIS PAGE CONTAINED HEADNOTES AND HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
</p></div>
<span CLASS="page_no" data-cite="683 f 3d 1358" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1358" data-primary-citation="683 F.3d 1356">[*1358]</span> <div id="para2" printdualcolumn="true"><p>
Paul H. Berghoff, McDonnell Boehnen Hulbert &amp; Berghoff, LLP, of Chicago,
Illinois, argued for plaintiff-appellant. With him on the brief was James V.
Suggs. Also on the brief was Patricia K. Schmidt, K &amp; L Gates LLP, of
Chicago, Illinois. Of counsel were Alan L. Barry and Jason A. Engel.
</p></div>
<div id="para2" printdualcolumn="true"><p>
James M. Bollinger, Troutman Sanders LLP, of New York, New York, argued for
defendant-cross appellant. With him on the brief were Laura E. Krawczyk and
Suraj K. Balusu. Of counsel were Timothy P. Heaton and Douglas D. Salyers.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before NEWMAN and BRYSON, Circuit Judges, and FOGEL, District Judge.<a HREF="#fn100" name="fnref_fn100">[fn1]</a>
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> Honorable Jeremy Fogel, District Judge, United States District Court
for the Northern District of California, sitting by designation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
BRYSON, Circuit Judge.
</p></div>
<div id="contentOpinion" printdualcolumn="true">
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Opinion for the court filed by Circuit Judge BRYSON. Concurring in part
and dissenting in part opinion filed by Circuit Judge NEWMAN.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Wm. Wrigley Jr. Co. and Cadbury Adams USA LLC compete in the consumer
market for chewing gum. This case involves chewing gum that provides a
cooling sensation when chewed. Historically, chewing gum makers have
achieved that cooling sensation (known as "physiological cooling") by adding
menthol to their products. Menthol, however, has disadvantages, including a
strong peppermint flavor and bitterness in high concentrations. During the
1970s and 1980s, Wilkinson-Sword Ltd. attempted to develop physiological
cooling agents that would not have the drawbacks of menthol. The result was
two such coolants, which were released under the trade names "WS-3" and
"WS-23." Wrigley and Cadbury each own a patent that generally claims chewing
gum containing a combination of menthol and one of those coolants. Cadbury
owns <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X2G00I84GOJ?jcsearch=usp%205009893&amp;summary=yes#jcite">U.S. Patent No. 5,009,893</a> ("the '<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X2G00I84GOJ?jcsearch=usp%205009893&amp;summary=yes#jcite">893 patent</a>"), which claims a chewing
gum that combines menthol with WS-3. Wrigley owns <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X31G8E21GOJ?jcsearch=usp%206627233&amp;summary=yes#jcite">U.S. Patent No. 6,627,233</a>
("the '233 patent"), which claims a chewing gum that combines menthol with
WS-23.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The application that matured into Cadbury's '893 patent was filed in July
1989. Claim 1, one of two independent claims of the '893 patent, recites:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      1. A chewing gum composition capable of providing long-lasting,
    breath freshening perception without bitterness comprising a gum
    base, a sweetener and a cooling composition comprising menthol and
    an N-substituted-p-menthane carboxamide of [a specific formula.]
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  WS-3 is an N-substituted-p-menthane carboxamide and one of the compounds
described by the formula recited in claim 1. The claim, therefore, reads on
chewing gum that combines WS-3 (and other N-substituted-p-menthane
carboxamides of
<span CLASS="page_no" data-cite="683 f 3d 1359" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1359" data-primary-citation="683 F.3d 1356">[*1359]</span> 
the recited formula) and menthol. The patent's specification discloses that
although the cooling effect of both menthol and WS-3 were known in the prior
art, the combination of the two "results in an unexpected heightened cooling
sensation in edible products." Cadbury introduced into the market a variety
of chewing gum products that embody the claims of the '893 patent. Those
products did well in the marketplace.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After Cadbury introduced its WS-3/menthol <span CLASS="page_no" data-cite="2012 bl 154971 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[***2]</span> chewing gum, Wrigley introduced
a chewing gum that combined menthol and WS-23. That product was the
commercial embodiment of claim 34 of Wrigley's '233 patent. The application
for the '233 patent was filed in March 2000. Claim 34 recites:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      34. A chewing gum composition comprising:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      a) about 5% to about 95% gum base;
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      b) about 5% to about 95% bulking and sweetening agent; and
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      c) about 0.1 [%] to about 10% flavoring agent wherein the
    flavoring agent comprises N-2, 3-trimethyl-2-isopropyl butanamide
    and menthol.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
WS-23 is the trade name for N-2, 3-trimethyl-2-isopropyl butanamide.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Following the introduction of Wrigley's WS-23/menthol chewing gum, Cadbury
reformulated some of its chewing gum products. <span CLASS="page_no" data-cite="103 uspq 2d 1132" data-cite-type="ReporterOfDecisions" data-cite-pageno="1132" data-primary-citation="103 U.S.P.Q.2d 1130">[**1132]</span> Cadbury's reformulated
chewing gum contained both WS-23 and menthol. Wrigley then filed suit
against Cadbury in the United States District Court for the Northern
District of Illinois, accusing Cad-burys reformulated chewing gum of
infringing the '233 patent. Cadbury counterclaimed, accusing Wrigley's
chewing gum of infringing Cadbury's '893 patent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Wrigley and Cadbury each moved for summary judgment on a number of issues.
Cadbury sought summary judgment declaring claim 34 of the '233 patent
invalid for obviousness and anticipation. Wrigley sought summary judgment
declaring that it had not infringed the asserted claims of the '893
patent.<a HREF="#fn200" name="fnref_fn200">[fn2]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court granted Wrigley's motion for summary judgment of
noninfringement of the '893 patent. The court first noted that WS-23 is not
an N-substituted-p-menthane carboxamide, so a combination of WS-23 and
menthol would not literally infringe the '893 patent. The court further
found that the '893 patent narrowly claimed the combination of
N-substituted-p-menthane carboxamides and menthol, and that it implicitly
excluded other carboxamides, including WS-23. The court therefore held that
a combination of WS-23 and menthol did not infringe the '893 patent under
the doctrine of equivalents.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Addressing Cadbury's summary judgment motion, the district court concluded
that claim 34 of the '233 patent was invalid on grounds of anticipation and
obviousness. The court held claim 34 to be anticipated by U.S. Patent No.
5,688,491 ("Shahidi"), and obvious in view of U.S. Patent No. 5,698,181
("Luo") and an article written by Dr. M.A. Parrish ("Parrish").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Shahidi is directed to a variety of oral compositions, each of which
contains xylitol and copper bis-glycinate. The compositions
<span CLASS="page_no" data-cite="683 f 3d 1360" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1360" data-primary-citation="683 F.3d 1356">[*1360]</span> 
include chewing gum as well as other compositions, such as toothpaste, mouth
rinses, and lozenges. Shahidi lists several categories of components that
can be included in the compositions. They include both "essential" and
"optional" (or "nonessential") components; certain of the optional
components are noted as "preferred." A "cooling agent or combination of
cooling agents" is such a "preferred nonessential" component. Some of the
categories further identify certain specific components as "preferred."
Within the category of cooling agents, Shahidi discloses WS-3 and WS-23 as
two of three "particularly preferred cooling agents." Shahidi also discloses
menthol as one of 23 listed flavoring agents that can be used in the claimed
compositions.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court found that Shahidi discloses every limitation of claim
34. <span CLASS="page_no" data-cite="2012 bl 154971 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[***3]</span> In making that determination, the district court relied on a patent,
incorporated by reference into Shahidi, which provided a range for the
amount of WS-23 to include in a composition. That range is a subset of the
range for the amount of flavoring agent recited in claim 34. The court
further ruled that Shahidi would have disclosed to one of ordinary skill in
the art how to create a cooling chewing gum with component amounts in the
ranges claimed by claim 34. The court therefore held that Shahidi
anticipated claim 34.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Luo discloses chewing gum that achieves a cooling effect by combining WS-3
and menthol, and it also discloses combining N-substituted-p-menthane
carboxamides with menthol. Parrish, which was published in 1987, describes
WS-3 and WS-23 as potential replacements for menthol in a variety of
applications, including chewing gum. Parrish highlights that both WS-3 and
WS-23 have "high cooling activity with no side-effects." Parrish does not
distinguish the cooling activity of WS-3 and WS-23, although it notes that
WS-3, but not WS-23, had been listed as "generally regarded as safe" by the
Flavor and Extract Manufacturers Association ("FEMA"). That approval,
referred to as "FEMA-GRAS listing," was subsequently extended to WS-23.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court held that, in light of the disclosures of Luo and
Parrish, the only novel aspect of claim 34 was the combination of menthol
and WS-23. Although Parrish teaches substituting WS-23 for menthol, rather
than combining the two, the court found that Parrish would have made it
obvious to substitute WS-23 for WS-3 in the combination of menthol and WS-3
that was disclosed in Luo. The court also ruled that the evidence of
secondary considerations proffered by Wrigley was not sufficient to overcome
the strong showing of obviousness and establish that claim 34 <span CLASS="page_no" data-cite="103 uspq 2d 1133" data-cite-type="ReporterOfDecisions" data-cite-pageno="1133" data-primary-citation="103 U.S.P.Q.2d 1130">[**1133]</span> was "an
invention appearing to have been obvious in light of the prior art [that]
was not." <i>Stratoflex, Inc. v. Aeroquip Corp.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X3UPG1?jcsearch=713%20f%202d%201530&amp;summary=yes#jcite">713 F.2d 1530</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X3UPG1?jcsearch=713%20f%202d%201530&amp;summary=yes#jcite">1538</a>
(Fed.Cir.1983).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>I</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On appeal, Wrigley argues that Shahidi does not anticipate claim 34 for
two reasons. First, Wrigley argues that while Shahidi discloses all the
claim limitations found in claim 34, it does not disclose them in the
combination recited in that claim.<a HREF="#fn300" name="fnref_fn300">[fn3]</a> Second, and relatedly, Wrigley
argues
<span CLASS="page_no" data-cite="683 f 3d 1361" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1361" data-primary-citation="683 F.3d 1356">[*1361]</span> 
that Shahidi would not have enabled a person of ordinary skill in the art to
derive the combination recited in claim 34 without undue experimentation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For a prior art reference to anticipate a claim, it must disclose all of
the limitations of the claim, "arranged or combined in the same way as in
the claim." <i>Net MoneyIN, Inc. v. VeriSign, Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X19QTGU003?jcsearch=545%20f%203d%201359&amp;summary=yes#jcite">545 F.3d 1359</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X19QTGU003?jcsearch=545%20f%203d%201359&amp;summary=yes#jcite">1370</a>
(Fed.Cir.2008). For example, in <i>Net MoneyIN</i>, this court held that an
"Internet payment system" was not anticipated by a prior art reference that
disclosed all the components of the invention, because the reference
disclosed two separate payment protocols, each of which contained only a
subset of the components claimed in the patent at issue. <i></i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X19QTGU003?jcsearch=545%20F.3d%201359&amp;summary=yes#jcite">Id. at 1371</a>.
Therefore, the reference did not "prove prior invention of the thing
claimed." <i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X19QTGU003?jcsearch=545%20F.3d%201359&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_921365" href="#headnote_pq2-dec_921365">[1]</a> In this case, by contrast, Shahidi envisions using WS-23 and menthol in a
single product. <span CLASS="page_no" data-cite="2012 bl 154971 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[***4]</span> While Shahidi discloses a number of different combinations
of cooling and flavoring elements, one of them is the combination of
menthol, which Shahidi identifies as one of the "most suitable" flavoring
agents, with WS-23, which Shahidi identifies along with WS-3 as among a
group of three "particularly preferred cooling agents." Based on the
disclosure of the combination of those components, we agree with the
district court that Shahidi anticipates claim 34.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This is not a case in which the prior art reference merely discloses a
genus and the claim at issue recites a species of that genus. In such a
case, the issue of anticipation turns on whether the genus was of such a
defined and limited class that one of ordinary skill in the art could "at
once envisage" each member of the genus. <i>Eli Lilly &amp; Co. v. Zenith Goldline</i>
<i>Pharm., Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X164AGG003?jcsearch=471%20f%203d%201369&amp;summary=yes#jcite">471 F.3d 1369</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X164AGG003?jcsearch=471%20f%203d%201369&amp;summary=yes#jcite">1376</a> (Fed.Cir.2006). Shahidi specifically
discloses WS-23 as a coolant and menthol as a flavoring agent. The question
for purposes of anticipation is therefore whether the number of categories
and components in Shahidi was so large that the combination of WS-23 and
menthol would not be immediately apparent to one of ordinary skill in the
art. <i>See Perricone v. Medicis Pharm. Corp.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X13PFME003?jcsearch=432%20f%203d%201368&amp;summary=yes#jcite">432 F.3d 1368</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X13PFME003?jcsearch=432%20f%203d%201368&amp;summary=yes#jcite">1377</a>
(Fed.Cir.2005) (distinguishing cases in which a prior art reference
discloses a genus from those in which it discloses a number of species as
part of a list).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Wrigley argues that <i>Impax Laboratories, Inc. v. Aventis Pharmaceuticals</i>
<i>Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X19NR1E003?jcsearch=545%20f%203d%201312&amp;summary=yes#jcite">545 F.3d 1312</a> (Fed.Cir.2008), stands for the proposition that a prior
art reference is not anticipatory if one of ordinary skill in the art would
be required to pick items from two lists of components in order to assemble
the invention. The issue in <i>Impax</i> was whether the use of the drug riluzole
for treating amyotrophic lateral sclerosis ("ALS") was anticipated by <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X2GGCC9200J?jcsearch=usp%205236940&amp;summary=yes#jcite">U.S.
Patent No. 5,236,940</a> ("the '940 patent"). <i></i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X19NR1E003?jcsearch=545%20F.3d%201312&amp;summary=yes#jcite">Id. at 1314</a>. The '940 patent
<span CLASS="page_no" data-cite="683 f 3d 1362" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1362" data-primary-citation="683 F.3d 1356">[*1362]</span> 
disclosed a formula that encompassed "hundreds or thousands of compounds."
<i></i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X19NR1E003?jcsearch=545%20F.3d%201312&amp;summary=yes#jcite">Id. at 1315</a>. The '940 patent also listed a number of diseases, including
ALS, that could potentially be treated with compounds of the disclosed
formula. <i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X19NR1E003?jcsearch=545%20F.3d%201312&amp;summary=yes#jcite">Id.</a></i> While we affirmed the district court's finding that undue
experimentation would have been required to practice the patent at issue in
<i>Impax</i>, there are important distinctions between that case and this one.
<span CLASS="page_no" data-cite="103 uspq 2d 1134" data-cite-type="ReporterOfDecisions" data-cite-pageno="1134" data-primary-citation="103 U.S.P.Q.2d 1130">[**1134]</span> Unlike the prior art reference at issue in <i>Impax</i>, where there was no
disclosed dosage information for using riluzole to treat ALS, <i>see <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X19NR1E003?jcsearch=545%20F.3d%201312&amp;summary=yes#jcite">id.</a></i>,
Shahidi discloses component amounts within the ranges claimed in claim 34.
Even more importantly, Shahidi specifically discloses the use of both WS-23
and menthol in chewing gum, whereas the only mention of riluzole in the
prior art reference in <i>Impax</i> was to disclaim it from the disclosed
invention. <i>See <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X19NR1E003?jcsearch=545%20F.3d%201312&amp;summary=yes#jcite">id.</a></i> ("the '940 patent . . . specifically excludes riluzole
from the invention").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Given the objective of the '233 patent, to obtain "a cooling flavor
composition that will contribute a long-lasting cooling sensation" and a
chewing gum with a "clean, high-quality flavor . . . with a good cooling
effect," the Shahidi reference clearly identifies the combination of WS-23,
which Shahidi identifies as one of three "particularly preferred" cooling
agents, and menthol, <span CLASS="page_no" data-cite="2012 bl 154971 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[***5]</span> which Shahidi identifies as being among the "most
suitable" flavoring ingredients.<a HREF="#fn400" name="fnref_fn400">[fn4]</a> The district court therefore correctly
held that Shahidi anticipates claim 34 of the '233 patent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>II</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Wrigley also argues that the district court erred in finding that the
combination recited in the '233 patent would have been obvious in light of
Luo and Parrish. In particular, Wrigley argues that the combination of WS-23
and menthol resulted in unexpected cooling, beyond what would have been
predicted by one of ordinary skill in the art.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_921366" href="#headnote_pq2-dec_921366">[2]</a> Evidence that a combination of known components results in an effect
greater than the predicted additive effect of the components can support a
finding of nonobviousness. See <i>Crocs, Inc. v. Int'l Trade Comm'n</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1CJGMG003?jcsearch=598%20f%203d%201294&amp;summary=yes#jcite">598 F.3d 1294</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1CJGMG003?jcsearch=598%20f%203d%201294&amp;summary=yes#jcite">1309</a> (Fed. Cir.2010) ("Even if the [patent at issue] were a
combination of known elements according to their established functions . . .
it yields more than predictable results [and therefore is] non-obvious.");
<i>Merck &amp; Co. v. Biocraft Labs., Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XAFL83?jcsearch=874%20f%202d%20804&amp;summary=yes#jcite">874 F.2d 804</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XAFL83?jcsearch=874%20f%202d%20804&amp;summary=yes#jcite">808</a> (Fed.Cir.1989). In
this case, however, the synergistic effect of combining coolants had already
been discovered, as reflected in the prior art. Luo disclosed a "synergy"
between menthol and WS-3, when menthol was included in high amounts, and
disclosed that the combination produced an "enhanced breath-freshening
effect" in which each component played "a vital role." Parrish identified
WS-3 and WS-23 as especially favored cooling agents for commercial use from
among 1200 tested compounds that induced a cooling effect. Moreover, Parrish
pointed to four characteristics shared by the WS-3 and WS-23 molecules that
were associated with their physiological cooling effect, suggesting
<span CLASS="page_no" data-cite="683 f 3d 1363" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1363" data-primary-citation="683 F.3d 1356">[*1363]</span> 
that the two compounds would likely have similar effects when ingested.
Therefore, to show that the cooling effect of the combination of WS-23 and
menthol was unexpected, Wrigley needed to demonstrate that the results were
unexpected to a significant degree beyond what was already known about the
effect of combining WS-3 and menthol. <i>See Ex parte Nutrasweet Co.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/1?citation=19%20U.S.P.Q.2d%201586&amp;summary=yes#jcite">19 U.S.P.Q.2d 1586</a>, <cite>1589</cite> (B.P.A.I. 1991) ("It would at least be necessary to
demonstrate that the improvements observed were greater to an unobvious
extent than those which would have been expected from the reference
teachings and that those differences were of some significant, practical
advantage.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As evidence that the claimed combination produced unexpected results and
drove the commercial success of Wrigley's chewing gums, Wrigley points to an
internal Cadbury study comparing Wrigley and Cadbury products. That study
concluded that the flavor and cooling features of Wrigley's products were
superior to those of the Cadbury products with which they were compared. The
study noted, however, that besides having a "newer, more advanced cooling
system," the tested Wrigley products differed from the comparable Cadbury
products in a number of other ways, including having sweetener levels three
times higher than Cadbury's products; more encapsulated sweeteners for
longer sweetness duration; higher gum base and filler levels that allowed
for a more efficient flavor release; and significantly <span CLASS="page_no" data-cite="2012 bl 154971 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[***6]</span> more expensive
ingredients. Moreover, the "cooling system" used in Wrigley's products was
not simply a combination of menthol and WS-23, as recited in claim 34 of the
'233 patent. Instead, as the district court noted, it was a formulation that
"contained <span CLASS="page_no" data-cite="103 uspq 2d 1135" data-cite-type="ReporterOfDecisions" data-cite-pageno="1135" data-primary-citation="103 U.S.P.Q.2d 1130">[**1135]</span> menthol and WS-23 along with several other ingredients," and the
menthol and WS-23 components were present in quantities not specifically
identified in claim 34. Therefore, Cadbury's study does not demonstrate that
the broadly claimed combination recited in claim 34 results in unexpected
cooling beyond the degree that was already predictable based on the prior
art.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The same analysis applies to Wrigley's argument that the commercial
success of its chewing gum containing menthol and WS-23 shows that the
claimed invention was nonobvious. As the district court noted, for
commercial success to be probative evidence of nonobviousness, a nexus must
be shown between the claimed invention and the evidence of commercial
success. In this case, the district court concluded, Wrigley failed to
establish such a nexus. Rather, the court observed, in the documents on
which Wrigley relies, "many factors were identified as contributing to
[Wrigley's commercial] success, including marketing efforts, the way in
which the gum was packaged, the amounts of gum base and sweeteners used, and
the cooling system used." In sum, the district court found "no evidence of
any nexus between the success of Wrigley's chewing gums covered by Claim 34
and the specific combination of menthol and WS-23," and therefore held that
"the fact that Wrigley's gums are successful does not alter the obviousness
analysis."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For the reasons given by the district court, we agree that Wrigley has not
established a sufficient nexus between the invention of claim 34 of the '233
patent and the success in the marketplace of its chewing gum products that
contain a combination of menthol and WS-23. Cadbury's internal study of
Wrigley's product showed that it differed from Cadbury's comparable product
in several ways that could have
<span CLASS="page_no" data-cite="683 f 3d 1364" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1364" data-primary-citation="683 F.3d 1356">[*1364]</span> 
contributed to the commercial success of Wrigley's gum. Because the evidence
does not show that the success of Wrigley's product was directly
attributable to combining WS-23, rather than WS-3, with menthol, the
district court properly discounted the evidence of commercial success as a
secondary consideration rebutting Cadbury's showing that the claimed
invention would have been obvious.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Wrigley also argues that evidence that Cadbury copied the combination of
WS-23 and menthol shows that the combination would not have been obvious. In
some cases, evidence that a competitor has copied a product embodying a
patented invention can be an indication of nonobviousness. <i>See Iron Grip</i>
<i>Barbell Co. v. USA Sports, Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XGA31H?jcsearch=392%20f%203d%201317&amp;summary=yes#jcite">392 F.3d 1317</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XGA31H?jcsearch=392%20f%203d%201317&amp;summary=yes#jcite">1325</a> (Fed.Cir.2004).
However, as the district court observed, "[j]ust as with the commercial
success analysis, a nexus between the copying and the novel aspects of the
claimed invention must exist for evidence of copying to be given significant
weight in an obviousness analysis." The district court acknowledged that
<span CLASS="page_no" data-cite="2012 bl 154971 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[***7]</span> Wrigley had shown through internal documents that Cadbury had sought to copy
Wrigley's invention by adding WS-23 to the cooling agents of some of its
products. But the court added that Wrigley had not shown evidence suggesting
that "the novel combination of WS-23 and menthol is what led Cadbury to copy
Wrigley's chewing gums," and in the absence of that evidence, the court
found that Wrigley had failed to establish the requisite nexus between
"Cadbury's copying and the merits of the claimed invention."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Besides the absence of evidence of a nexus between Cadbury's copying and
Wrigley's claimed invention, there is evidence suggesting the contrary. In
particular, the evidence shows that in the market for chewing gum the
parties have a practice of marketing very similar products. While Cadbury's
internal documents show that it sought to reformulate its products to match
Wrigley's products, that desire extended not just to the inclusion of WS-23,
but to the inclusion of similar sweeteners and similar levels of each.
Wrigley's evidence of copying is therefore not a strong indicator of
nonobviousness, but rather a measure of the extent to which parties in the
chewing gum market typically copy any development by their competitors,
whether patented or not.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This case presents a strong case of obviousness based on the prior art
references of record. Claim 34 recites a combination of elements that were
all known in the prior art, and all that was required to obtain that
combination was to substitute one well-known cooling agent for another. Luo
taught the physiological cooling effect from combining menthol with WS-3.
Parrish showed that WS-3 and WS-23 were the two most attractive cooling
agents for commercial use from among 1200 cooling agents tested. Shahidi
taught the combination of menthol and cooling agents, of <span CLASS="page_no" data-cite="103 uspq 2d 1136" data-cite-type="ReporterOfDecisions" data-cite-pageno="1136" data-primary-citation="103 U.S.P.Q.2d 1130">[**1136]</span> which WS-3 and
WS-23 were two of the three most preferred candidates. And a prior art 1995
patent owned by The Procter &amp; Gamble Company (<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X2H0K24010J?jcsearch=usp%205451404&amp;summary=yes#jcite">U.S. Patent No. 5,451,404</a>),
specifically refers to the combination of menthol and WS-23, along with
other components, in a composition designed to produce physiological
cooling. Under these circumstances, it is fair to say that there were "a
finite number of identified, predictable solutions" to the problem of
finding physiological cooling agents for chewing gum, and that the
combination of menthol and WS-23 was "the product not of innovation but of
ordinary
<span CLASS="page_no" data-cite="683 f 3d 1365" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1365" data-primary-citation="683 F.3d 1356">[*1365]</span> 
skill and common sense." <i>KSR Int'l Co. v. Telefax Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XRIK7VQNB5G0?jcsearch=550%20us%20398&amp;summary=yes#jcite">550 U.S. 398</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XRIK7VQNB5G0?jcsearch=550%20us%20398&amp;summary=yes#jcite">421</a>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XRIK7VQNB5G0?jcsearch=127%20supreme%20court%201727&amp;summary=yes#jcite">127 S.Ct. 1727</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XRIK7VQNB5G0?jcsearch=167%20l%20ed%202d%20705&amp;summary=yes#jcite">167 L.Ed.2d 705</a> (2007). This case is thus one in which a
person of ordinary skill in the art would find it "obvious to try" the
combination recited in claim 34. <i>Id.</i> We therefore uphold the district
court's conclusion that, even in light of the evidence of secondary
considerations, claim 34 would have been obvious in light of Luo and
Parrish.<a HREF="#fn500" name="fnref_fn500">[fn5]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>III</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In its cross-appeal, Cadbury argues that the district court made two
errors regarding the '893 patent, both of which involve whether chewing gum
formulations that combine menthol with WS-23 are within the patent's scope.
First, Cadbury argues that in its claim construction ruling the district
court <span CLASS="page_no" data-cite="2012 bl 154971 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[***8]</span> improperly found that the '893 patent disclaimed certain compounds,
including WS-23. Second, Cadbury argues that the court erred in ruling that
the doctrine of equivalents could not be used to extend the reach of the
'893 patent to cover a chewing gum containing a combination of menthol and
WS-23.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In its opening claim construction brief, Cadbury argued that the term
"N-substituted-p-menthane carboxamide" should be construed according to its
ordinary meaning. Wrigley responded that the '893 patent should be read to
exclude all compounds other than N-substituted-p-menthane carboxamides. That
would exclude WS-23, which is not an N-substituted-p-menthane carboxamide.
In its reply brief on claim construction, Cadbury argued that the patent did
not disclaim compounds other than "WS-3 and its related carboxamides," and
in particular that the patent did not disclaim WS-23. The district court
agreed with Wrigley that the '893 patent disclaimed all compounds other than
N-substituted-p-menthane carboxamides and construed the term
"N-substituted-p-menthane carboxamide" to mean "a class of molecules with
the chemical formulas set forth in Claims 1 and 12 of the '893 Patent."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On appeal, all parties now agree that the claimed N-substituted-p-menthane
carboxamides do not include WS-23. Wrigley's products are therefore plainly
not within the literal scope of the claims of the '893 patent. While Cadbury
argues that Wrigley's products infringe under the doctrine of equivalents,
we agree with the district court that WS-23 is not an equivalent of WS-3 for
purposes of the '893 patent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_921367" href="#headnote_pq2-dec_921367">[3]</a> As the district court noted, the disclosure of the '893 patent focuses
narrowly on N-substituted-p-menthane carboxamides, and not on carboxamides
generally. The "Summary of the Invention" section states that "[a]pplicants
have unexpectedly found that N-substituted-p-menthane carboxamides
<span CLASS="page_no" data-cite="683 f 3d 1366" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1366" data-primary-citation="683 F.3d 1356">[*1366]</span> 
when used in combination with menthol in specific amounts results in an
unexpected heightened cooling sensation in edible products." The
specification adds that certain species of N-substituted-p-menthane
carboxamides &mdash; and not carboxamides generally &mdash; "are quite similar
structurally to menthol itself." While there is some dispute as to the
mechanism by which WS-3 and WS-23 provide cooling sensation, it is clear
that WS-23 is not structurally similar to menthol in the same way that
N-substituted-p-menthane carboxamides are. Finally, the claims themselves
are narrow, not even claiming all N-substituted-p-menthane carboxamides, but
only a subset of those compounds. <span CLASS="page_no" data-cite="103 uspq 2d 1137" data-cite-type="ReporterOfDecisions" data-cite-pageno="1137" data-primary-citation="103 U.S.P.Q.2d 1130">[**1137]</span> <i>See Tanabe Seiyaku Co. v. Int'l Trade</i>
<i>Comm'n</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X4UUMO?jcsearch=109%20f%203d%20726&amp;summary=yes#jcite">109 F.3d 726</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X4UUMO?jcsearch=109%20f%203d%20726&amp;summary=yes#jcite">732</a> (Fed.Cir.1997) (narrow language in the claims and
specification can preclude use of doctrine of equivalents to reach beyond
what is literally claimed); see <i>also Bicon, Inc. v. Straumann Co.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X14HUGS003?jcsearch=441%20f%203d%20945&amp;summary=yes#jcite">441 F.3d 945</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X14HUGS003?jcsearch=441%20f%203d%20945&amp;summary=yes#jcite">955</a> (Fed.Cir.2006) ("A claim that contains a detailed
recitation of structure is properly accorded correspondingly limited
recourse to the doctrine of equivalents.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Cadbury's argument that <i>Abraxis Bioscience, Inc. v. Mayne Pharma Inc.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X15VMF4003?jcsearch=467%20f%203d%201370&amp;summary=yes#jcite">467 F.3d 1370</a> (Fed.Cir.2006), compels a different result is unavailing. The
issue in <i>Abraxis</i> was whether diethylenetriaminepentaacetic acid ("DTPA")
could be considered <span CLASS="page_no" data-cite="2012 bl 154971 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[***9]</span> as an equivalent of edetate. Both compounds belonged to
"a broad class of structurally analogous compounds known as
polyaminocarboxylic acids." <i></i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X15VMF4003?jcsearch=467%20F.3d%201370&amp;summary=yes#jcite">Id. at 1379</a> n. 7. The patentee, however, had
narrowly claimed edetate. <i></i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X15VMF4003?jcsearch=467%20F.3d%201370&amp;summary=yes#jcite">Id. at 1381</a>. We rejected the argument that such
narrow claiming precluded the patentee from arguing that DPTA was an
equivalent of edetate. <i></i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X15VMF4003?jcsearch=467%20F.3d%201370&amp;summary=yes#jcite">Id. at 1380</a>. In so finding, we relied on the fact
that it was unknown at the time of the invention that the properties of DTPA
made it a suitable substitute for edetate in the claimed invention. <i></i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X15VMF4003?jcsearch=467%20F.3d%201370&amp;summary=yes#jcite">Id. at
1381-82</a>. Because it was unknown that DTPA and edetate were interchangeable,
the patentee had no reason to claim DTPA, and we therefore held that DTPA
could be considered to be within the scope of the patent under the doctrine
of equivalents. <i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X15VMF4003?jcsearch=467%20F.3d%201370&amp;summary=yes#jcite">Id</a>; see also Kinzenbaw v. Deere &amp; Co.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XABORE?jcsearch=741%20f%202d%20383&amp;summary=yes#jcite">741 F.2d 383</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XABORE?jcsearch=741%20f%202d%20383&amp;summary=yes#jcite">389</a>
(Fed.Cir.1984) ("The doctrine of equivalents is designed to protect
inventors from unscrupulous copyists and unanticipated equivalents.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The facts of this case support the opposite inference. The inventors of
the '893 patent were introduced to WS-3 and WS-23 by a salesman for Sterling
Organics, the distributor of the compounds, during the same sales call, and
they were told that the two compounds were appropriate for the same uses.
Although the fact that WS-23 did not enjoy FEMA-GRAS listing at the time of
the invention might have prevented Cadbury from marketing a chewing gum
containing a combination of WS-23 and menthol, it would not have precluded
the inventors from anticipating that WS-23 could be used as a substitute for
WS-3. Thus, the inventors were on notice of the potential interchangeability
of WS-23 and WS-3, yet they drafted the claims of the '893 patent narrowly
to recite certain N-substituted-p-menthane carboxamides, not a broader
category of carboxamides that would include WS-23. The trial court therefore
properly held that Cadbury could not expand the coverage of its patent to
include WS-23 through the doctrine of equivalents.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Each party shall bear its own costs for this appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>AFFIRMED</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> This appeal concerns Wrigley's "production" gum. Cadbury moved for
summary judgment that certain experimental chewing gum produced by Wrigley
infringed the '893 patent. The district court denied that motion, and
Cadbury has not pursued that issue on appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> Cadbury contends that in the district court Wrigley failed to make
that argument, as well as its argument that unexpected results show the '233
patent was not obvious. For that reason, Cadbury contends, Wrigley has
waived those arguments. We conclude that Wrigley presented the essence of
its present arguments to the district court sufficiently to preserve those
arguments for appeal. <i>See Warner-Lambert Co. v. Teva Pharm. USA, Inc.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X12LP0K003?jcsearch=418%20f%203d%201326&amp;summary=yes#jcite">418 F.3d 1326</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X12LP0K003?jcsearch=418%20f%203d%201326&amp;summary=yes#jcite">1338</a> n. 11 (Fed.Cir.2005). In the district court, Wrigley
argued that because Shahidi disclosed "a large number of optional or
non-essential categories of ingredients," it did not disclose "the
combination of 'menthol' and WS-23 in a chewing gum composition." Although
in much abbreviated form, that is essentially the same argument Wrigley
makes as to anticipation on appeal. As for obviousness, Wrigley's argument
as to unexpected results was also skimpy, but it asserted that "the
performance of WS-23 in combination with menthol in chewing gum applications
would not have been predicted by one of ordinary skill in the art," which
was enough to preserve the "unexpected results" argument for appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> While the dissent notes that Shahidi listed a number of flavoring
agents, a person of ordinary skill in the art would recognize menthol as
extremely well known in the prior art for inclusion in a cooling gum. The
fact that one of ordinary skill in the art might also have included other
flavorings would not remove the resulting composition from the broad reach
of claim 34.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> We do not adopt a "formal burden-shifting framework," <i>see In re</i>
<i>Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1HF6KC003?jcsearch=676%20f%203d%201063&amp;summary=yes#jcite">676 F.3d 1063</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1HF6KC003?jcsearch=676%20f%203d%201063&amp;summary=yes#jcite">1077</a> (Fed.Cir.2012), nor did the district court. As noted in
<i>Cyclobenzaprine</i>, use of the terms "prima facie" and "rebuttal" in addressing
an invalidity challenge does not constitute reversible error as long as the
court "consider[s] <i>all</i> evidence of obviousness and nonobviousness before
reaching a determination" and does not shift the burden from the patent
challenger. <i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1HF6KC003?jcsearch=2012%20BL%2092043&amp;summary=yes#jcite">Id</a>.</i> In this case, the district court addressed the objective
considerations put forth by Wrigley prior to making a determination of
obviousness. The district court in <i>Cyclobenzaprine</i>, by contrast, concluded
that "the invention was obvious" before considering the objective factors.
<i>In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1FEQ8E003?jcsearch=794%20f%20supp%202d%20517&amp;summary=yes#jcite">794 F.Supp.2d 517</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1FEQ8E003?jcsearch=794%20f%20supp%202d%20517&amp;summary=yes#jcite">537</a> (D.Del.2011).
</p></div>
</div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  NEWMAN, Circuit Judge, concurring in part, dissenting in part.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I concur in Part III of the court's opinion, and agree that Wrigley does
not infringe
<span CLASS="page_no" data-cite="683 f 3d 1367" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1367" data-primary-citation="683 F.3d 1356">[*1367]</span> 
Cadbury's '893 patent. However,. I must dissent from Parts I and II. I would
sustain the validity of Wrigley's '233 patent, for the district court
departed from the routine correct law of obviousness and anticipation. On
the correct law, the district court's decisions on these grounds are not
supportable.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I. Obviousness
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  To be patentable, the subject matter must be unobvious in view of what has
gone before. This determination is made by examiners in the Patent and
Trademark Office; and when that agency's grant of a patent is challenged in
litigation, the court applies the analytical protocol set forth in <i>Graham v.</i>
<i>John Deere Co.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X5C6EI?jcsearch=383%20us%201&amp;summary=yes#jcite">383 U.S. 1</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X5C6EI?jcsearch=86%20supreme%20court%20684&amp;summary=yes#jcite">86 S.Ct. 684</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X5C6EI?jcsearch=15%20l%20ed%202d%20545&amp;summary=yes#jcite">15 L.Ed.2d 545</a> (1966), and
reconfirmed by the Court in <i>KSR International Co. v. Teleflex Inc.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XRIK7VQNB5G0?jcsearch=550%20us%20398&amp;summary=yes#jcite">550 U.S. 398</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XRIK7VQNB5G0?jcsearch=127%20supreme%20court%201727&amp;summary=yes#jcite">127 S.Ct. 1727</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XRIK7VQNB5G0?jcsearch=167%20l%20ed%202d%20705&amp;summary=yes#jcite">167 L.Ed.2d 705</a> (2007). In litigation the
burden of proof is on the challenger by clear and convincing evidence, for
the patent as granted by the agency is presumed valid.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Graham</i> the Court set forth four factual areas on which the
determination of obviousness is based: (1) the scope and content of the
prior art, (2) the differences between the prior art and <span CLASS="page_no" data-cite="2012 bl 154971 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[***10]</span> the claimed
invention, (3) the level of ordinary skill in the field of the invention,
and (4) any objective factors such as commercial success, long-felt but
unsolved need, and copying by others. <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X5C6EI?jcsearch=383%20us%201&amp;summary=yes#jcite">383 U.S. at 17-18</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X5C6EI?jcsearch=86%20supreme%20court%20684&amp;summary=yes#jcite">86 S.Ct. 684</a>. The
district court erred in its treatment of the fourth factor, for as explained
in <i>Simmons Fastener Corp. v. Illinois Tool Works, Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X3J69G?jcsearch=739%20f%202d%201573&amp;summary=yes#jcite">739 F.2d 1573</a> (Fed.
Cir.1984):
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      <span CLASS="page_no" data-cite="103 uspq 2d 1138" data-cite-type="ReporterOfDecisions" data-cite-pageno="1138" data-primary-citation="103 U.S.P.Q.2d 1130">[**1138]</span> The <cite>section 103</cite> test of nonobviousness set forth in <i>Graham</i> is a
    four part inquiry comprising, not only the three familiar elements
    (scope and content of the prior art, differences between the prior
    art and the claims at issue, and level of ordinary skill in the
    pertinent art), but also evidence of secondary considerations when
    such evidence is, of course, present.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i></i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X3J69G?jcsearch=739%20F.2d%201573&amp;summary=yes#jcite">Id. at 1575</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court, and my colleagues on this panel, err by holding that
Cadbury established a prima facie case of obviousness on prior art alone,
<i>viz.</i>, the Luo and Parrish references. It is agreed that these references do
not show the Wrigley composition. When the evidence of commercial success
and copying by the infringer is considered, a prima facie case of
obviousness is not demonstrated. In <i>Stratoflex, Inc. v. Aeroquip Corp.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X3UPG1?jcsearch=713%20f%202d%201530&amp;summary=yes#jcite">713 F.2d 1530</a> (Fed.Cir.1983) the court explained that "evidence of secondary
considerations may often be the most probative and cogent evidence in the
record. It may often establish that an invention appearing to have been
obvious in light of the prior art was not. It is to be considered as part of
all the evidence, not just when the decisionmaker remains in doubt after
reviewing the art."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court, holding that a prima facie case of obviousness was
established on the prior art alone, shifted the burden of proof to the
patentee to rebut the asserted, but improper, prima facie case with the
evidence of commercial success and copying. This is a distortion of the
burden of proof, which never leaves the challenger, <i>see In re</i>
<i>Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1HF6KC003?jcsearch=676%20f%203d%201063&amp;summary=yes#jcite">676 F.3d 1063</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1HF6KC003?jcsearch=676%20f%203d%201063&amp;summary=yes#jcite">1078</a> (Fed.Cir.2012) ("[T]he Supreme Court has never imposed
nor even contemplated a formal burden-shifting framework in the patent
litigation context."). It is also a distortion of reasoned
<span CLASS="page_no" data-cite="683 f 3d 1368" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1368" data-primary-citation="683 F.3d 1356">[*1368]</span> 
analysis for, as the Court stated in <i>Graham</i>, "[s]uch secondary
considerations as commercial success, long felt but un-solved needs, failure
of others, etc., might be utilized to give light to the circumstances
surrounding the origin of the subject matter sought to be patented."
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X5C6EI?jcsearch=383%20us%201&amp;summary=yes#jcite">383 U.S. at 17-18</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X5C6EI?jcsearch=86%20supreme%20court%20684&amp;summary=yes#jcite">86 S.Ct. 684</a>. All of the circumstances must be
considered.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The panel majority affirms the district court's misplaced analysis,
agreeing that the Luo and Parrish references present a prima facie case of
obviousness and that the burden of rebuttal shifts to the patentee. Maj. op.
at 1363 ("Therefore, to show that the cooling effect of the combination of
WS-23 and menthol was unexpected, Wrigley needed to demonstrate that the
results were unexpected to a significant degree beyond what was already
known about the effect of combining WS-3 and menthol"). The cited references
indeed show relevant information. The Luo reference shows WS-3 in
combination with menthol, and mentions the generic class of
N-substituted-p-menthane <span CLASS="page_no" data-cite="2012 bl 154971 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[***11]</span> carboxamides, but does not mention WS-23. The
Parrish reference mentions both WS-3 and WS-23 as replacements for menthol,
but does not show the combination of either WS-3 or WS-23 with menthol.
Wrigley provided a large amount of evidence, much of it from Cadbury's
records, of the unexpected results and commercial success of the combination
of WS-23 with menthol.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The evidence established that (1) although WS-3 alone is two to three
times more effective as a coolant in chewing gum than WS-23 alone, when
combined with menthol WS-23 is not only more effective, but is sufficiently
more effective such that there is a vast preference among gum-chewers; and
(2) Cadbury observed its major loss of sales to the new Wrigley gum,
analyzed the Wrigley product, concluded that the WS-23 menthol combination
was responsible for the consumer preference, and then copied the Wrigley
product. This information surely colors the understanding of the prior art,
as seen by a person of ordinary skill in the field of the invention, for the
improved properties that produced the striking consumer preference for
Wrigley's new composition are nowhere signaled in the cited references.
These objective considerations are not consigned to rebuttal, for they are
direct evidence of obviousness.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court erred in holding the '233 composition prima facie
obvious on only part of the evidence, ignoring the evidence that supports
unobviousness. As remarked by Judge Learned Hand, "Courts, made up of laymen
as they must be, are likely either to underrate, or to overrate, the
difficulties in making new and profitable discoveries in fields with which
they cannot be familiar; and, so far as it is available, they had best
appraise the originality involved by the circumstances which preceded,
attended and succeeded the appearance of the invention." <i>Safety Car Heating</i>
<i>&amp; Lighting Co. v. General Elec. Co.<span CLASS="page_no" data-cite="103 uspq 2d 1139" data-cite-type="ReporterOfDecisions" data-cite-pageno="1139" data-primary-citation="103 U.S.P.Q.2d 1130">[**1139]</span> </i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X3C7P9?jcsearch=155%20f%202d%20937&amp;summary=yes#jcite">155 F.2d 937</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X3C7P9?jcsearch=155%20f%202d%20937&amp;summary=yes#jcite">939</a> (2d Cir.1946).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The advantageous properties of the Wrigley combination of WS-23 and
menthol are not predicted or suggested or even hinted in any reference. My
colleagues on this panel hold that "Wrigley needed to demonstrate that the
results were unexpected to a significant degree beyond what was already
known about the cooling effects of WS-3 and menthol." Maj. op. at 1363. This
criterion, although unwarranted, was surely met. Cadbury's own test report
states that although WS-3 alone exhibits a cooling intensity three
<span CLASS="page_no" data-cite="683 f 3d 1369" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1369" data-primary-citation="683 F.3d 1356">[*1369]</span> 
times that of WS-23, when combined with menthol "WS-23 cooling technology
was positively correlated with increased overall liking and also with flavor
and cooling intensity at 5 minutes and ten minutes." JA. 3320. This
observation has no foreshadow in the prior art. It is highly relevant, and
on the facts of this case precludes summary judgment of obviousness.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Nonetheless, the district court states, and my colleagues agree, that
there was "no evidence of any nexus between the success of Wrigley's chewing
gums covered by Claim 34 and the specific combination of menthol and WS-23."
Maj. op. at 1363. The record is rife with such evidence. Cadbury's own
records specifically <span CLASS="page_no" data-cite="2012 bl 154971 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[***12]</span> identify the combination of WS-23 and menthol as "key
drivers for liking." J.A. 3310; J.A. 2996-3000. As further evidence of a
clear and undisputed nexus, Wrigley points to marketing material that
stresses the cooling effect of its WS-23 reformulated chewing gums,
describing the gums as "Even More Powerful," producing "Icy Cool Breath That
Lasts," and generating a "Just Brushed Clean Feeling;" and that "It's
Cooler, Longer Lasting and MORE ICY!" J.A. 3012; J.A. 3261-62; J.A. 2981.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Similarly, after Cadbury copied Wrigley's formulation using WS-23, Cadbury
advertised its new product's "New Taste. New Chill" and "Now. Cooler.
Longer." Advertising the benefits of the claimed invention links the
invention to commercial success. <i>Cf. Gambro Lundia AB v. Baxter Healthcare</i>
<i>Corp.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X31Q3I?jcsearch=110%20f%203d%201573&amp;summary=yes#jcite">110 F.3d 1573</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X31Q3I?jcsearch=110%20f%203d%201573&amp;summary=yes#jcite">1579</a> (Fed.Cir.1997) ("The prominence of the patented
technology in . . . advertising creates an inference that links the . . .
invention to this success."). No contrary evidence was offered to the strong
evidence of a nexus between the invention and its market success. "To the
extent that the patentee demonstrates the required nexus, his objective
evidence of nonobviousness will be accorded more or less weight." <i>In re GPAC</i>
<i>Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X39MC3?jcsearch=57%20f%203d%201573&amp;summary=yes#jcite">57 F.3d 1573</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X39MC3?jcsearch=57%20f%203d%201573&amp;summary=yes#jcite">1580</a> (Fed.Cir.1995). "Once the patentee demonstrates a
prima facie nexus, the burden of coming forward with evidence in rebuttal
shifts to the challenger." <i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X39MC3?jcsearch=57%20F.3d%201573&amp;summary=yes#jcite">Id</a>.</i> No such rebuttal evidence was presented.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  My colleagues' finding that nexus was not established, maj. op. at
1363-64, is hard to fathom. Cadbury's own documents showed that Cadbury
changed its formulation to copy Wrigley's new gums containing WS-23 and
menthol. A Cad-bury internal report states that Cadbury expected that if it
did not reformulate its gums, it would lose market share at a cost in the
United States of "$2MM in Year 1, then $3.5MM, $5.0MM, and $7.0MM in
subsequent years and projects that maximum lost sales would amount to half
of the brand growth projected on Dentyne Ice to be at risk (approx. $25MM
per year)." J.A. 2984. The Cadbury report states that Wrigley's gums use a
"newer, more advanced cooling system than WS-3" and that "cooling" and
"breath freshening" are "key drivers of [consumer] loyalty." J.A. 2985.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Contrary to my colleagues' hypothesis, the fact that Cadbury also copied
Wrigley's sweeteners does not negate the un-disputed record that Cadbury
copied the composition of WS-23 with menthol in order to obtain the improved
cooling of this composition, an effect that both competitors advertised for
these products. Cadbury's internal documents state that Cad-bury copied the
Wrigley cooling system because it was "more advanced" and "preferred" by
consumers over Cadbury's product which used WS-3 with menthol.
<span CLASS="page_no" data-cite="683 f 3d 1370" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1370" data-primary-citation="683 F.3d 1356">[*1370]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  It is not disputed that the superior properties of the WS-23 menthol
combination were not shown or suggested in the prior art. The district court
erred in its application of the <i>Graham</i> factors by asking whether the
evidence of secondary considerations were sufficient to overcome its "final
conclusion" that the patent is obvious. D.Ct. op. at 42 (citing <i>Leapfrog</i>
<i>Enterprises, Inc. v. Fisher-Price, Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X16PSAM003?jcsearch=485%20f%203d%201157&amp;summary=yes#jcite">485 F.3d 1157</a> (Fed.Cir.2007) for
the proposition that "the evidence on secondary <span CLASS="page_no" data-cite="2012 bl 154971 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[***13]</span> considerations was
inadequate to overcome a final conclusion" of obviousness). "Evidence of
secondary considerations, <span CLASS="page_no" data-cite="103 uspq 2d 1140" data-cite-type="ReporterOfDecisions" data-cite-pageno="1140" data-primary-citation="103 U.S.P.Q.2d 1130">[**1140]</span> including evidence of unexpected results and
commercial success, are but a part of the `totality of the evidence' that is
used to reach the ultimate conclusion of obviousness." <i>Richardson-Vicks Inc.</i>
<i>v. Upjohn Co.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X36F9U?jcsearch=122%20f%203d%201476&amp;summary=yes#jcite">122 F.3d 1476</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X36F9U?jcsearch=122%20f%203d%201476&amp;summary=yes#jcite">1483</a> (Fed.Cir.1997); <i>see also Cyclobenzaprine</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1HF6KC003?jcsearch=676%20f%203d%201063&amp;summary=yes#jcite">676 F.3d at 1079-80</a> ("[O]pinions of this court should not be read to require
a burden-shifting framework in derogation of <i>Stratoflex's</i> directive that
objective evidence be considered before making an obviousness determination
and in disregard of where the burdens of proof and persuasion are properly
placed in district court litigation.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A court may not presuppose that, regardless of the evidence of commercial
success and unexpected results, the invention is obvious based on prior art
alone. The secondary indicia of nonobviousness must be considered in
deciding whether a prima facie case of obviousness has been presented. <i>See</i>
<i>Stratoflex</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X3UPG1?jcsearch=713%20f%202d%201530&amp;summary=yes#jcite">713 F.2d at 1538</a> ("It is jurisprudentially inappropriate to
disregard any relevant evidence on any issue in any case, patent cases
included. Thus evidence rising out of the so-called `secondary
considerations' must always when present be considered en route to a
determination of obviousness."); <i>Ashland Oil, Inc. v. Delta Resins &amp;</i>
<i>Refractories, Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XABR7B?jcsearch=776%20f%202d%20281&amp;summary=yes#jcite">776 F.2d 281</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XABR7B?jcsearch=776%20f%202d%20281&amp;summary=yes#jcite">306</a> (Fed.Cir.1985) ("Just as it is legal
error for a district court to fail to consider relevant evidence going to
secondary considerations, it may be legal error for a district court to
presuppose that all evidence relating to secondary considerations, when
considered with the other <i>Graham</i> indicia relating to the
obviousness/nonobviousness issue, cannot be of sufficient probative value to
elevate the subject matter of the claimed invention to the level of
patentable invention.") (internal citation omitted); <i>Pentec, Inc. v. Graphic</i>
<i>Controls Corp.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XABR7M?jcsearch=776%20f%202d%20309&amp;summary=yes#jcite">776 F.2d 309</a> (Fed.Cir.1985) ("Objective evidence of
nonobviousness, when present, must always be considered before reaching a
legal conclusion under <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XEIVVE003?jcsearch=35%20U.%20S.%20C.%20%20103&amp;summary=yes#jcite">&sect; 103</a>"); <i>Kan. Jack, Inc. v. Kuhn</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X46152?jcsearch=719%20f%202d%201144&amp;summary=yes#jcite">719 F.2d 1144</a>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X46152?jcsearch=719%20f%202d%201144&amp;summary=yes#jcite">1150-51</a> (Fed.Cir.1983) (finding that a district court's consideration of
commercial success complied with "the basic requirement that all evidence
touching the obvious-nonobvious issue be fully considered before a
conclusion is reached on that issue"); <i>Richardson-Vicks</i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X36F9U?jcsearch=122%20f%203d%201476&amp;summary=yes#jcite">122 F.3d at 1483</a> ("we
must consider all of the evidence under the <i>Graham</i> factors before reaching
our decision"); <i>In re Mageli et al</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XII0R7?jcsearch=470%20f%202d%201380&amp;summary=yes#jcite">470 F.2d 1380</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XII0R7?jcsearch=470%20f%202d%201380&amp;summary=yes#jcite">1384</a> (CCPA 1973)
(evidence bearing on issue of nonobviousness "is never of `no moment,' is
always to be considered and accorded whatever weight it may have."). To the
extent this court has made statements to the contrary, <i>e.g., Wyers v. Master</i>
<i>Lock Co.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1DMPC6003?jcsearch=616%20f%203d%201231&amp;summary=yes#jcite">616 F.3d 1231</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1DMPC6003?jcsearch=616%20f%203d%201231&amp;summary=yes#jcite">1246</a> (Fed.Cir.2010) ("secondary considerations of
nonobviousness &mdash; considered here by the district court &mdash; simply cannot
overcome a strong prima facie case of obviousness"), earlier precedent
controls. <i>See Newell Cos., Inc. v. Kenney Mfg. Co.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X4AJDK?jcsearch=864%20f%202d%20757&amp;summary=yes#jcite">864 F.2d 757</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X4AJDK?jcsearch=864%20f%202d%20757&amp;summary=yes#jcite">765</a> (Fed.
Cir.1988) ("[P]rior decisions of a panel of the court are binding precedent
on subsequent
<span CLASS="page_no" data-cite="683 f 3d 1371" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1371" data-primary-citation="683 F.3d 1356">[*1371]</span> 
panels unless and until overturned in banc")
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court erred in granting summary judgment of <span CLASS="page_no" data-cite="2012 bl 154971 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[***14]</span> obviousness, for
the criteria for summary judgment of invalidity on this ground were clearly
not met. I respectfully dissent from the court's contrary ruling.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  II. Anticipation
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court also granted summary judgment of invalidity on the
ground of anticipation, not relying on any reference cited for obviousness,
but relying on a different reference that does not show the claimed
combination at all, but merely presents the ingredients on lists.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The term "anticipation" in patent law means that the invention was
previously known. If the invention was known, it is anticipated. The
district court found "anticipation" by a reference that presents lists of
hundreds of possible ingredients of chewing gum, from which the district
court, and now this court, select Wrigley's components WS-23 and menthol.
The purported anticipatory reference does not show this combination, and
does not present so short and selective a list of these ingredients as to
warrant an inference that their combination was already known. The Shahidi
patent, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X2HH0G44G8J?jcsearch=usp%205688491&amp;summary=yes#jcite">U.S. Patent No. 5,688,491</a> (the '491 patent), on which the district
court and my colleagues rely, contains lists of many known ingredients that
might be used in an assortment of products including chewing gums,
dentifrices, and mouth-washes. Shahidi's lists include humectants,
surfactants, thickeners, abrasives, stannous salts, copper salts, flavoring
<span CLASS="page_no" data-cite="103 uspq 2d 1141" data-cite-type="ReporterOfDecisions" data-cite-pageno="1141" data-primary-citation="103 U.S.P.Q.2d 1130">[**1141]</span> agents, sweeteners, and cooling agents, which can be combined in over a
million possible combinations, <i>see</i> Wrigley Br. 18. Shahidi names three known
preferred cooling agents: WS-3, WS-23, and TK-10, as well as a large number
of other cooling agents in five identified U.S. Patents. '491 patent col.4
11.14-32.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Shahidi also states that flavoring agents "well known in the art" can be
used, naming anise, cassia, clove dihydroanethole, estragole, eucalyptol,
menthol, methyl salicylate, peppermint, axanone, phenyl ethyl alcohol, sweet
birch, eugenol, spearmint, cinnamic aldehyde, menthone, alpha-ionone, ethyl
vanillin, limonene, isoamylacetate, benzaldehyde, thymol, ethylbutryate, and
"many others." <i>Id.</i> at col.7 ll.16-22. Shahidi does not describe any specific
composition containing either WS-23 or menthol, nor the combination of WS-23
and menthol for any purpose. Nonetheless, my colleagues affirm the district
court's grant of summary judgment, and hold that Shahidi "anticipates" the
Wrigley composition of WS-23 and menthol. That is an incorrect understanding
of the law of "anticipation."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court apparently went astray in applying this court's ruling
in <i>Perricone v. Medicis Pharmaceutical Corp.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X13PFME003?jcsearch=432%20f%203d%201368&amp;summary=yes#jcite">432 F.3d 1368</a> (Fed.Cir.2005),
for the district court states that it suffices to anticipate if the
ingredients WS-23 and menthol can be found somewhere on Shahidi's lists,
although Shahidi shows only long lists of possible ingredients for Shahidi's
unrelated compositions. <i>Perricone</i> does not hold that a specific unknown
composition is deemed known if its components can be found separately on
lists of possible components. <i>See </i><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X13PFME003?jcsearch=432%20F.3d%201368&amp;summary=yes#jcite">id. at 1375-76</a>. It is the scope,
specificity, and content of the list that controls whether the disclosure is
so specific <span CLASS="page_no" data-cite="2012 bl 154971 p 15" data-cite-type="Bloomberg" data-cite-pageno="15" data-primary-citation="">[***15]</span> as to be deemed a disclosure of specific combinations.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This court has explained that, in order to anticipate, the prior art must
be such
<span CLASS="page_no" data-cite="683 f 3d 1372" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1372" data-primary-citation="683 F.3d 1356">[*1372]</span> 
that a person of ordinary skill would "at once envisage" the specific
claimed composition. <i>Impax Labs., Inc. v. Aventis Pharms. Inc.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1609Q2003?jcsearch=468%20f%203d%201366&amp;summary=yes#jcite">468 F.3d 1366</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1609Q2003?jcsearch=468%20f%203d%201366&amp;summary=yes#jcite">1383</a> (Fed. Cir.2006); <i>In re Petering</i>, 49 CCPA 993,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XIF1BJ?jcsearch=301%20f%202d%20676&amp;summary=yes#jcite">301 F.2d 676</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/XIF1BJ?jcsearch=301%20f%202d%20676&amp;summary=yes#jcite">681</a> (1962). When the listing of many possible ingredients does
not produce immediate recognition of the specific combination, the list does
not "anticipate" that combination. My colleagues misconstrue <i>Pemricone</i>, for
that case does not rely on the distinction between a list and a genus in
determining whether the claimed invention is "new," and does not hold that
every list, of whatever form and length and complexity, anticipates every
combination of the listed components. In <i>Perricone</i> the list contained
fourteen ingredients, including ascorbyl palmitate, for use in cosmetic
cream, and the court held that this anticipated claims to ascorbyl palmitate
for use in cosmetic cream. <i>Perricone</i> did not hold that all lists are
anticipating, as a matter of law. Rather, <i>Perricone</i> alerts the trier of fact
to the factual nature of "anticipation," and the specific circumstances
whereby a specific product on a list may be found to be identified for the
patentee's specific composition.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court erred in viewing <i>Perricone</i> as holding that "the mere
fact that the elements of a claim are set forth in the prior art patent in a
list along with the other ingredients without any `special emphasis' is
irrelevant to an anticipation analysis. Instead, all that is relevant is
whether the prior art disclosure is enabling." D.Ct. op. at 27 (internal
citation omitted). To the contrary, the way the elements are set forth in
the reference and its lists is highly relevant, for an anticipating
reference must show the specific ingredients and direct their selection such
that the specific combination is deemed to have existed. <i>See Impax Labs.</i>,
<a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1609Q2003?jcsearch=468%20f%203d%201366&amp;summary=yes#jcite">468 F.3d at 1383</a> (the specific combination must be at once envisaged).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  It was not disputed that a person of ordinary skill would not at once
envisage Wrigley's combination of WS-23 and menthol from Shahidi's lists.
<i>See Eli Lilly &amp; Co. v. Zenith Goldline Pharms., Inc.</i>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X164AGG003?jcsearch=471%20f%203d%201369&amp;summary=yes#jcite">471 F.3d 1369</a>, <a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X164AGG003?jcsearch=471%20f%203d%201369&amp;summary=yes#jcite">1375</a>
(Fed.Cir.2006) ("To anticipate, a prior art reference must place the
inventive compound or composition in the possession of the public"). From
the large number of listed ingredients and possible combinations of
ingredients, and the absence of any selection of the combination of WS-23
and menthol in chewing gum, Shahidi does not anticipate the combination of
WS-23 and menthol in chewing gum. From the court's erroneous ruling of law
and its incorrect application, I respectfully dissent.
</p></div>
<!--BBLS DD 1714597855235-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HSQVU003/history">Direct History (8)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HSQVU003/analysis">Case Analysis (11)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1HSQVU003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
11
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Consumer Goods</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1Q6LGC0K5O2">11-01140 (Fed. Cir.)</a></div><div class='facetItemLabel'><a href="/s/opinion/58c2f496a749056dc16e85a8d800c33c/document/X1Q6LGG3F682">11-01150 (Fed. Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Patent Law</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/58c2f496a749056dc16e85a8d800c33c/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "58c2f496a749056dc16e85a8d800c33c";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY0bb615&previousPageId=&previousActivityInstanceId=ENTITYd9b08d&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:55:44-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1HSQVU003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITYd9b08d&previousPageId=&previousActivityInstanceId=ENTITY54a163&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:55:41-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1HSQVU003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1HSQVU003";
$('#page_loader').show().spin();
JUDGE_IDS=["1850676","3027440"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
